{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:11:38Z","timestamp":1790097098885,"version":"4.0.1"},"reference-count":24,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>As outpatient chemotherapy has become increasingly common, family members may be exposed to anticancer drugs in daily life through contact with patients' body fluids and contaminated environments. However, little is known in Japan about family members' perceptions of household exposure to anticancer drugs. In this study, we explored family members' perceptions of household exposure to anticancer drugs and their information needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews were conducted with six cohabiting family members of patients receiving outpatient cytotoxic anticancer drug therapy. The data were analyzed using a qualitative descriptive approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven categories were identified and integrated into a storyline. Family members had an incomplete understanding of household exposure to anticancer drugs and expressed concerns about its potential effects on themselves and other family members. Some questioned the risks of such exposure, and all participants prioritized the patient's treatment and expressed a willingness to follow recommended preventive measures if provided with information about exposure. Perceptions of exposure risks differed according to family composition, and participants wanted information about currently available knowledge, potential risks, and preventive measures despite the limited evidence regarding household exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These exploratory findings suggest that healthcare professionals should provide information about household exposure to anticancer drugs not only to patients but also to family members living with them, even when evidence is limited. Information provision could be tailored to individual family circumstances because perceptions of exposure risks may differ according to family composition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261485533","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:58:57Z","timestamp":1789819137000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Perceptions and information needs regarding household exposure to anticancer drugs among family members living with patients receiving outpatient chemotherapy in Japan: A qualitative descriptive study"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-1896","authenticated-orcid":false,"given":"Maho","family":"Miyazawa","sequence":"first","affiliation":[{"name":"Department of Social Pharmacy, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan"},{"name":"Department of Pharmacy, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Saitama Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-8138","authenticated-orcid":false,"given":"Keiko","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy, Showa Medical University Graduate School of Pharmacy, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212459667"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1188\/15.ONF.42-06AP"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1188\/18.ONF.597-606"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13737"},{"key":"e_1_3_3_6_2","first-page":"3","article-title":"The family life adjustment living with cancer patient undergoing outpatient chemotherapy","volume":"16","author":"Doi F","year":"2019","unstructured":"Doi F, Ito M, Nomura M. The family life adjustment living with cancer patient undergoing outpatient chemotherapy. J Kanagawa Univ Hum Serv 2019; 16: 3\u201313.","journal-title":"J Kanagawa Univ Hum Serv"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-023-01313-2"},{"key":"e_1_3_3_8_2","first-page":"83","article-title":"The education of outpatients and their families on the prevention of exposure to antineoplastic drugs","volume":"23","author":"Sugiyama R","year":"2015","unstructured":"Sugiyama R, Ishii N, Kudo Y, et al. The education of outpatients and their families on the prevention of exposure to antineoplastic drugs. Bull Grad Sch Health Sci Akita Univ 2015; 23: 83\u201392.","journal-title":"Bull Grad Sch Health Sci Akita Univ"},{"key":"e_1_3_3_9_2","first-page":"133","article-title":"The status of education for patients and their family members on how to prevent exposure to anticancer drugs when handling bodily excretions","volume":"30","author":"Hayama Y","year":"2021","unstructured":"Hayama Y, Shiratori S, Kamiya J, et al. The status of education for patients and their family members on how to prevent exposure to anticancer drugs when handling bodily excretions. J Jpn Health Med Assoc 2021; 30: 133\u2013141.","journal-title":"J Jpn Health Med Assoc"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.5649\/jjphcs.49.88"},{"key":"e_1_3_3_11_2","volume-title":"The perception of risk","author":"Slovic P.","year":"2000","unstructured":"Slovic P. The perception of risk. Routledge, 2000."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"e_1_3_3_14_2","first-page":"101","article-title":"Social desirability bias in qualitative health research","volume":"56","author":"Bispo JP. Jr.","year":"2022","unstructured":"Bispo JP. Jr. Social desirability bias in qualitative health research. Rev Saude Publica 2022; 56: 101.","journal-title":"Rev Saude Publica"},{"key":"e_1_3_3_15_2","volume-title":"Guidelines for Preventing Occupational Exposure in Cancer Chemotherapy Drugs","author":"Japanese Society of Cancer Nursing, Japanese Society of Medical Oncology and Japanese Society of Pharmaceutical Oncology","year":"2019","unstructured":"Japanese Society of Cancer Nursing, Japanese Society of Medical Oncology and Japanese Society of Pharmaceutical Oncology. Guidelines for Preventing Occupational Exposure in Cancer Chemotherapy Drugs. 2019 ed. Kanehara Shuppan, 2019.","edition":"2019"},{"key":"e_1_3_3_16_2","volume-title":"Safe handling of hazardous drugs","author":"Olsen MM","year":"2024","unstructured":"Olsen MM, Walton AL. Safe handling of hazardous drugs. 4th ed. Oncology Nursing Society, 2024.","edition":"4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"ISOPP Standards for the safe handling of cytotoxics. J Oncol Pharm Pract. 2022 Apr; 28: S1\u2013S126.","DOI":"10.1177\/10781552211070933"},{"key":"e_1_3_3_18_2","volume-title":"Chemotherapy and You: Support for People with Cancer","author":"National Cancer Institute","unstructured":"National Cancer Institute. Chemotherapy and You: Support for People with Cancer. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2022\u20132024."},{"key":"e_1_3_3_19_2","volume-title":"Risk communication: a mental models approach","author":"Morgan MG","year":"2002","unstructured":"Morgan MG, Fischhoff B, Bostrom A, et al. Risk communication: a mental models approach. Cambridge University Press, 2002."},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13853-y"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b25-00521"},{"key":"e_1_3_3_22_2","first-page":"3143","article-title":"Patient navigation moderates emotion and information demands of cancer treatment: a qualitative analysis","volume":"22","author":"Rousseau SJ","unstructured":"Rousseau SJ, Humiston SG, Yosha A, et al. Patient navigation moderates emotion and information demands of cancer treatment: a qualitative analysis. Support Care Cancer 2014 Dec; 22: 3143\u20133151.","journal-title":"Support Care Cancer"},{"key":"e_1_3_3_23_2","first-page":"521","article-title":"Qualitative assessment of unmet information management needs of informal cancer caregivers: four themes to inform oncology practice","volume":"4","author":"Crotty BH","unstructured":"Crotty BH, Asan O, Holt J, et al. Qualitative assessment of unmet information management needs of informal cancer caregivers: four themes to inform oncology practice. JCO Clin Cancer Inform 2020 Jun; 4: 521\u2013528.","journal-title":"JCO Clin Cancer Inform"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01550-5"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732315617444"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261485533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261485533","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261485533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:50:54Z","timestamp":1790095854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261485533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":24,"alternative-id":["10.1177\/10781552261485533"],"URL":"https:\/\/doi.org\/10.1177\/10781552261485533","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"article-number":"10781552261485533"}}